The chromatin remodelling protein LSH/HELLS regulates the amount and distribution of DNA hydroxymethylation in the genome

Epigenetics. 2022 Apr;17(4):422-443. doi: 10.1080/15592294.2021.1917152. Epub 2021 May 7.

Abstract

Ten-Eleven Translocation (TET) proteins convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) leading to a dynamic epigenetic state of DNA that can influence transcription and chromatin organization. While TET proteins interact with complexes involved in transcriptional repression and activation, the overall understanding of the molecular mechanisms involved in TET-mediated regulation of gene expression still remains limited. Here, we show that TET proteins interact with the chromatin remodelling protein lymphoid-specific helicase (LSH/HELLS) in vivo and in vitro. In mouse embryonic fibroblasts (MEFs) and embryonic stem cells (ESCs) knock out of Lsh leads to a significant reduction of 5-hydroxymethylation amount in the DNA. Whole genome sequencing of 5hmC in wild-type versus Lsh knock-out MEFs and ESCs showed that in absence of Lsh, some regions of the genome gain 5hmC while others lose it, with mild correlation with gene expression changes. We further show that differentially hydroxymethylated regions did not completely overlap with differentially methylated regions indicating that changes in 5hmC distribution upon Lsh knock-out are not a direct consequence of 5mC decrease. Altogether, our results suggest that LSH, which interacts with TET proteins, contributes to the regulation of 5hmC levels and distribution in MEFs and ESCs.

Keywords: DNA hydroxymethylation; DNA methylation; LSH; TET; chromatin; gene expression; remodelling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Methylcytosine / metabolism
  • Animals
  • Chromatin Assembly and Disassembly*
  • Cytosine / metabolism
  • DNA / metabolism
  • DNA Helicases / metabolism
  • DNA Methylation*
  • Fibroblasts / metabolism
  • Genome
  • Mice

Substances

  • 5-Methylcytosine
  • Cytosine
  • DNA
  • DNA Helicases
  • Hells protein, mouse

Grants and funding

MdD and LC were supported by the F.N.R.S. MdD also wishes to thank Région Ile-de-France (Domaine Intérêt Majeur en Biothérapies), Fondation pour la Recherche Médicale and Labex “Who am I?” for post-doctoral fellowships. MBi was supported by the Télévie. This work was funded by grants from the Fonds de la Recherche Scientifique and Télévie, as well as by grants from the IUAP [P7/03 program], the Action de Recherche Concerté [AUWB-2010-2015 ULB-No 7], the Belgian “Foundation against Cancer”, the WB Health program, and the Fonds Gaston Ithier. Research in IS lab was supported by Cancer Research UK senior fellowship [C7215/A8983]. Research in BM lab is supported by the Labex “Who Am I?”[#ANR-11-LABX-0071] and the Université de Paris IdEx [#ANR-18-IDEX-0001] funded by the French Government through its “Investments for the Future” program.